Clinical Trials Logo

Clinical Trial Summary

The objective of this prospective enrollment study is to collect data confirming safety, performance and clinical benefits of the CoMatryx Surgical Collagen powder at a minimum 1-year follow-up and compare it to a historical control group who did not receive the product at the time of surgery. The primary objective is to confirm safety and clinical benefits of the product. This will be assessed by recording the rate of wound healing and incidence and frequency of wound care related complications. Relationship of complications to the product should be specified.


Clinical Trial Description

The CoMatryx Surgical Collagen powder is a soft tissue repair product made of 100% Type I Bovine collagen. It is non-hydrolyzed and not cross-linked chemically. It is biocompatible, biodegradable and free of synthetics. The product does not have any specific storage requirements. The CoMatryx Surgical Collagen powder provides a physiologically favorable environment to promote healing at the wound site. When administered, the powder conforms to the wound site and forms a gelatinous occlusive barrier. Along with providing 19 amino acids directly to the wound site it also occludes live nerve endings reducing pain. Treating the wound with the CoMatryx Surgical Collagen powder provides the non-hydrolyzed collagen wound surface promoting autolytic debridement. The powder is effective in all phases of wound healing and can be delivered with antibiotics in areas where there may be a cavity. This product has FDA 510(k) clearance for surgical wounds, full thickness wounds, traumatic wounds and skin tears. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04407364
Study type Observational
Source MPM Medical
Contact Scott Miller
Phone 9728934049
Email scott.miller@mpmmed.com
Status Recruiting
Phase
Start date September 2, 2020
Completion date January 2, 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT06190015 - Impact of Advanced Platelet Rich Fibrin and Enamel Matrix Derivative on Clinical and Molecular Wound Healing Parameters After Surgical Removal of Mandibular Third Molars Phase 4
Completed NCT05716490 - Optimizing Closed Incision Negative Pressure Wound Therapy in Emergency Laparotomy N/A
Withdrawn NCT04038671 - Activated Carbon Interphase Effect on Surgical Incisions vs.Two Common Wound Dressings N/A